Loading clinical trials...
Loading clinical trials...
ImPact on QualIty Of Life From Multi-modality Treatment for Lung caNcEr: A Randomised Controlled fEasibility tRial of Surgery Versus no Surgery as Part of Multi-modality Treatment in Potentially Resectable Stage III-N2 NSCLC (The PIONEER Trial)
Conditions
Interventions
Surgery
No surgery
Locations
2
United Kingdom
Salford Royal NHS Foundation Trust
Salford, Greater Manchester, United Kingdom
Manchester University Foundation Trust- Wythenshawe
Manchester, United Kingdom
Start Date
November 25, 2020
Primary Completion Date
August 31, 2022
Completion Date
January 31, 2023
Last Updated
February 3, 2022
NCT07444697
NCT07143110
NCT06819592
NCT07412379
NCT06885697
NCT07221422
Lead Sponsor
The Christie NHS Foundation Trust
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions